{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:50:20Z","timestamp":1773197420344,"version":"3.50.1"},"reference-count":31,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":1515,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:p>We previously reported that S-propargyl-cysteine (SPRC) exerts cardioprotective effects by elevating H2S levels via the CSE\/H2S pathway. In the present study, we investigated the cardioprotective effects and pharmacokinetic properties of a controlled release formulation of SPRC (CR-SPRC) in an in\u00a0vivo rat model of myocardial infarction (MI). Rats were randomly assigned to seven groups that were pre-treated with CR-SPRC daily for 7\u00a0days prior to ligation of the left anterior descending coronary artery to induce MI. Cardiac function and infarct size were determined after MI, and we examined the activity of antioxidant enzymes, expression of anti-inflammation proteins and hydrogen sulfide levels. Mixed-mode, reversed-phase and cation-exchange HPLC\u2013MS\/MS were used to compare the pharmacokinetic properties of CR-SPRC and SPRC. CR-SPRC significantly reduced infarct size and creatine kinase (CK) and lactate dehydrogenase (LDH) leakage and it preserved cardiac function during MI. CR-SPRC displayed antioxidant properties, preserving glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) levels whereas reducing malondialdehyde (MDA) levels. Moreover, CR-SPRC significantly reduced the protein levels of inflammatory biomarkers (phospho-NF-\u03baB p65\/NF-\u03baB p65, TNF-\u03b1) and increased cystathionine-\u03b3-lyase (CSE) and I\u03ba-B\u03b1 protein levels. CR-SPRC had better pharmacokinetic properties than SPRC, with a reduced concentration peak (Cmax), prolonged time to reach peak concentration (Tmax), prolonged mean residence time (MRTinf) and increased AUC0\u2013t. CR-SPRC showed protective effects against MI via the CSE\/H2S pathway and demonstrated better cardioprotective effects than SPRC by prolonging the release of endogenous H2S.<\/jats:p>","DOI":"10.1042\/bsr20140185","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T09:00:43Z","timestamp":1430384443000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction"],"prefix":"10.1042","volume":"35","author":[{"given":"Ba\u00a0Hieu","family":"Tran","sequence":"first","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengrong","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhou","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrui","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujun","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u00a0Zhun","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, Shanghai, China"},{"name":"School of Pharmacy & Institutes of Biomedical Sciences, Fudan University, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"2021111618405334200_B1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"2021111618405334200_B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","article-title":"The immune system and cardiac repair","volume":"58","author":"Frangogiannis","year":"2008","journal-title":"Pharmacol. Res."},{"key":"2021111618405334200_B3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/1568010033484098","article-title":"Inflammatory mechanisms in myocardial infarction","volume":"2","author":"Ren","year":"2003","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"2021111618405334200_B4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00726-011-0834-1","article-title":"S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism","volume":"41","author":"Pan","year":"2011","journal-title":"Amino Acids"},{"key":"2021111618405334200_B5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1089\/ars.2009.2947","article-title":"Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production","volume":"12","author":"Wang","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"2021111618405334200_B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/FJC.0b013e3181ac8e12","article-title":"S-propargylcysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia\/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway","volume":"54","author":"Wang","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021111618405334200_B7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/j.1745-7254.2007.00629.x","article-title":"Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential","volume":"28","author":"Chen","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"2021111618405334200_B8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"key":"2021111618405334200_B9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/ars.2011.4349","article-title":"Role of cystathionine \u03b3-lyase\/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?","volume":"17","author":"Pan","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"2021111618405334200_B10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SHK.0b013e318180ff89","article-title":"Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I\/R","volume":"31","author":"Sivarajah","year":"2009","journal-title":"Shock"},{"key":"2021111618405334200_B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/BSR20100003","article-title":"Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection","volume":"31","author":"Wang","year":"2011","journal-title":"Biosci. Rep."},{"key":"2021111618405334200_B12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbrc.2004.04.094","article-title":"Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol","volume":"318","author":"Geng","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111618405334200_B13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2006.10.058","article-title":"Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells","volume":"351","author":"Yan","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111618405334200_B14","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1074\/jbc.M109.071274","article-title":"Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation","volume":"285","author":"Zhu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021111618405334200_B15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00018-009-0250-9","article-title":"Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages","volume":"67","author":"Zhu","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"2021111618405334200_B16","doi-asserted-by":"publisher","first-page":"e19766","DOI":"10.1371\/journal.pone.0019766","article-title":"Hydrogen sulfide attenuated tumor necrosis factor-\u03b1-induced inflammatory signaling and dysfunction in vascular endothelial cells","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"key":"2021111618405334200_B17","doi-asserted-by":"publisher","first-page":"878052","DOI":"10.1155\/2012\/878052","article-title":"Hydrogen sulfide as an endogenous modulator in mitochondria and mitochondria dysfunction","volume":"2012","author":"Guo","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2021111618405334200_B18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci."},{"key":"2021111618405334200_B19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/aps.2013.127","article-title":"Hydrogen sulfide and translational medicine","volume":"34","author":"Guo","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"2021111618405334200_B20","doi-asserted-by":"publisher","first-page":"e69205","DOI":"10.1371\/journal.pone.0069205","article-title":"Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"2021111618405334200_B21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3317\/jraas.2000.039","article-title":"Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction","volume":"1","author":"Zhu","year":"2000","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"2021111618405334200_B22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jpba.2010.11.027","article-title":"Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC\u2013MS\/MS method and its application to pharmacokinetic studies","volume":"54","author":"Zheng","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"2021111618405334200_B23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2021111618405334200_B24","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1096\/fj.01-0260com","article-title":"\u03b1-Lipoic acid inhibits TNF-\u03b1-induced NF-\u03ba\u03b2 activation and adhesion molecule expression in human aortic endothelial cells","volume":"15","author":"Zhang","year":"2001","journal-title":"FASEB J."},{"key":"2021111618405334200_B25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/CCM.0b013e3181c0df00","article-title":"Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis","volume":"38","author":"Ang","year":"2010","journal-title":"Crit. Care Med."},{"key":"2021111618405334200_B26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1189\/jlb.0407237","article-title":"Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture induced sepsis","volume":"82","author":"Zhang","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"2021111618405334200_B27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1096\/fj.04-3583fje","article-title":"Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"2021111618405334200_B28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/ars.2010.3671","article-title":"Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease","volume":"15","author":"Kida","year":"2011","journal-title":"Antioxid. Redox. Signal."},{"key":"2021111618405334200_B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1527-3466.2006.00077.x","article-title":"Oxidative stress as the leading cause of acute myocardial infarction in diabetics","volume":"24","author":"Filippo","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"2021111618405334200_B30","doi-asserted-by":"publisher","first-page":"S747","DOI":"10.1161\/CIRCULATIONAHA.109.854562","article-title":"Delivery of SOD with polyketal particles protects rats from acute myocardial infarction","volume":"120","author":"Davis","year":"2009","journal-title":"Circulation"},{"key":"2021111618405334200_B31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1096\/fj.04-2289fje","article-title":"NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes","volume":"19","author":"Peng","year":"2005","journal-title":"FASEB J."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20140185\/428843\/bsr035e216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20140185\/428843\/bsr035e216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:08:43Z","timestamp":1637089723000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/35\/3\/e00216\/56678\/Cardioprotective-effects-and-pharmacokinetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20140185","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]},"article-number":"e00216"}}